Efficacy and safety of haemopoietic stem cell transplant (HSCT) for mucopolysaccharidosis type I-Hurler syndrome (MPS-IH): a systematic review.

Patel M, Bean K, Pang F, Tian MX, Chen MJ, Stirk L, Armstrong N

Open source

DOI
10.1186/s13287-026-05155-6
Published
2026 Aug 12
Container
Stem cell research & therapy
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s13287-026-05155-6,
  title = {Efficacy and safety of haemopoietic stem cell transplant (HSCT) for mucopolysaccharidosis type I-Hurler syndrome (MPS-IH): a systematic review.},
  author = {Patel M and Bean K and Pang F and Tian MX and Chen MJ and Stirk L and Armstrong N},
  year = {2026},
  journal = {Stem cell research \& therapy},
  doi = {10.1186/s13287-026-05155-6},
  url = {https://doi.org/10.1186/s13287-026-05155-6}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of haemopoietic stem cell transplant (HSCT) for mucopolysaccharidosis type I-Hurler syndrome (MPS-IH): a systematic review.
AU  - Patel M
AU  - Bean K
AU  - Pang F
AU  - Tian MX
AU  - Chen MJ
AU  - Stirk L
AU  - Armstrong N
PY  - 2026
JO  - Stem cell research & therapy
DO  - 10.1186/s13287-026-05155-6
UR  - https://doi.org/10.1186/s13287-026-05155-6
ER  - 

APA

M, P., K, B., F, P., MX, T., MJ, C., L, S., & N, A. (2026). Efficacy and safety of haemopoietic stem cell transplant (HSCT) for mucopolysaccharidosis type I-Hurler syndrome (MPS-IH): a systematic review.. Stem cell research & therapy. https://doi.org/10.1186/s13287-026-05155-6

Source records